207 results
Page 3 of 11
6-K
ys9ngv3n afc
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
m1209dtz q4mu
11 May 23
Current report (foreign)
6:07am
6-K
wm6upxnqaplu6j7oq6ru
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
nbd5y4c3 kh3yv
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
nu2t61c
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
v38ml1
30 Nov 22
Current report (foreign)
6:28am
6-K
agrz87g
4 Nov 22
Current report (foreign)
6:01am
6-K
sa20tu 5y4le
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
qscajr4znve
27 Oct 22
Current report (foreign)
6:01am
6-K
pl6cikzub rmwure
14 Oct 22
Current report (foreign)
7:36am
6-K
9oz r6ues8bnw519yc
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
n3mcy7w
23 Aug 22
Current report (foreign)
6:13am
6-K
6avu p4knavn37d
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
12ht12
4 Aug 22
Current report (foreign)
6:07am
6-K
33lq5 mn5p0t
28 Jul 22
Current report (foreign)
6:09am
6-K
EX-99.1
aaqfjv8 nix1w9t8
28 Jul 22
Current report (foreign)
6:09am
6-K
tknxx40k
11 Jul 22
Current report (foreign)
6:05am
6-K
updfqr ptta0k
29 Jun 22
Current report (foreign)
6:02am
6-K
x9i5kpze t74db0
31 May 22
Current report (foreign)
6:20am